MERCK & CO., INC. (MRK)
Clinical trial NCT05231122 updates: 1. completion date: 2026-12-30 → 2027-03-15 2. primary completion date: 2026-12-30 → 2027-03-15
Clinical trial NCT05231122 updates: 1. completion date: 2026-12-30 → 2027-03-15 2. primary completion date: 2026-12-30 → 2027-03-15
📉 **NEGATIVE** • Low confidence analysis (51%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical